US2007088317A1PendingUtilityA1
Catheters and methods of using catheters
Individually held — no corporate assignee on recordPriority: Jun 27, 2002Filed: Sep 27, 2006Published: Apr 19, 2007
Est. expiryJun 27, 2022(expired)· nominal 20-yr term from priority
Inventors:Gregory M. Hyde
A61N 5/062A61M 25/1002A61B 17/22A61B 2017/22087A61B 2017/22085A61M 25/10A61N 5/0601A61M 2025/1095A61M 2025/105
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A catheter device and method, in which a first lumen coupled to a balloon, a second lumen coupled to the first lumen, the second lumen having a distal opening to dispense an oxygenated infusate, and a third lumen coupled to the second lumen and coupled to a second balloon. The second balloon restricts the flow of the oxygenated infusate, and the oxygenated infusate provides oxygen to tissue at a distal end of said catheter device.
Claims
exact text as granted — not AI-modified1 - 5 . (canceled)
6 . A method of treating a body vessel, said method comprising:
inserting a catheter device comprising at least one lumen near a treatment site within said body vessel; expanding a first inflatable member of said catheter device disposed upstream from said treatment site to obstruct blood flow; infusing an oxygenated infusate through said catheter device and into said body vessel near said treatment site; expanding a second inflatable member of said catheter device disposed downstream from said treatment site to reduce downstream flow rate where said oxygenated infusate can flow past said second inflatable member and perfuse portions of said body vessel downstream from said treatment site.
7 . The method of claim 6 , wherein said oxygenated infusate further comprises a light activated bioagent.
8 . The method of claim 6 , wherein said second inflatable member further comprises a balloon with variable diameter.
9 . The method of claim 6 , wherein said catheter device further comprises a light diffuser disposed between said first inflatable member and said second inflatable member.
10 . The method of claim 9 , wherein expanding said second inflatable member increases a resonance time for said light activated bioagent to infuse into said treatment site.
11 . A method of treating a body vessel, said method comprising:
inserting a catheter device including two inflatable members, a light diffuser and an infusion port into said body vessel near a treatment site; expanding a first inflatable member proximal to said treatment site to occlude flow to said treatment site; expanding a second inflatable member distal to said treatment site to reduce flow from said treatment site to portions of the vessel downstream from said second inflatable member; infusing an oxygenated and light activated infusate through said infusion port about said treatment site; and shining a light, capable of activating said oxygenated and light activated infusate, from said light diffuser about said treatment site.
12 . The method of claim 111 wherein said two inflatable members are of different constructions.
13 . The method of claim 12 wherein said two inflatable members are of different shapes.
14 . The method of claim 11 wherein said light diffuser and said infusion ports are disposed between said two inflatable members.
15 . The method of claim 11 wherein said oxygenated and light activated infusate includes a drug to treat at least one of atherosclerosis, vessel occlusion and vessel inflammation.
16 . The method of claim 15 wherein light at a particular frequency (or wavelength) and intensity is released from said light diffuser to activate light activated bioactive agent released from the infusion port.
17 . The method of claim 15 wherein a light source for said light diffuser is at least one of a fiber optic assembly and a LED.
18 . The method of claim 11 wherein the said second inflatable member is a balloon that has a variable diameter that forms perfusion paths along the balloon's outer surface.
19 . A method of treating a body vessel, said method comprising:
inserting a catheter device including two inflatable members and infusion ports into said body vessel near a treatment site; expanding a first inflatable member disposed near a proximal end of the catheter device to occlude flow; expanding a second inflatable member disposed near a distal end of the catheter device to partially impede a downstream flow; and infusing an oxygenated and light activated infusate through said infusion ports and into said body vessel.
20 . The method of claim 19 wherein the two inflatable members are of different constructions.
21 . The method of claim 20 wherein the oxygenated and light activated further comprises a drug to treat at least one of atherosclerosis, vessel occlusion and vessel inflammation.
22 . The method of claim 21 wherein said infusion ports and an additional light diffuser are both located between the two inflatable members.
23 . The method of claim 22 wherein the light diffuser is capable of activating said light activated bioactive agent by shining a light from said light diffuser to said body vessel.
24 . The method of claim 23 wherein light at a particular frequency (or wavelength) and intensity is released from said light diffuser to activate said infusate released from the infusion port.
25 . The method of claim 24 wherein a light source for said light diffuser is at least one of a fiber optic assembly and a LED.
26 . A medical device, comprising:
a catheter with at least a proximal inflatable member and a distal inflatable member; the proximal inflating member, after inflated, to occlude flow from upstream; the distal inflating member, after inflated, to allow partial flow downstream; and an oxygenated infusate infusion port displaced on the catheter device.
27 . The medical device of claim 26 wherein the two inflatable members are of different constructions to control flow of blood or infusate.
28 . The medical device of claim 27 wherein the distal inflatable member is a helical balloon.
29 . The medical device of claim 26 wherein a light activated bioagent is mixed with the oxygenated infusate.
30 . The medical device of claim 29 wherein a light diffuser is also displaced on the catheter device and a light source for the light diffuser is at least one of a fiber optic assembly and a LED.
31 . The medical device of claim 30 wherein light at a particular frequency (or wavelength) and intensity is released from said light diffuser to activate said light activated bioagent.
32 . The medical device of claim 30 wherein both the light diffuser and the oxygenated infusate infusion port are both displaced between the two inflating members.Join the waitlist — get patent alerts
Track US2007088317A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.